Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Express Scripts
AstraZeneca
Baxter
Daiichi Sankyo
QuintilesIMS
Johnson and Johnson
Covington

Generated: April 21, 2018

DrugPatentWatch Database Preview

HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% Drug Profile

« Back to Dashboard

Which patents cover Heparin Sodium 5,000 Units In Sodium Chloride 0.9%, and when can generic versions of Heparin Sodium 5,000 Units In Sodium Chloride 0.9% launch?

Heparin Sodium 5,000 Units In Sodium Chloride 0.9% is a drug marketed by Hospira and B Braun and is included in two NDAs.

The generic ingredient in HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% is heparin sodium. There are seventy-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%
Drug patent expirations by year for HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%
Pharmacology for HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%

US Patents and Regulatory Information for HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% heparin sodium INJECTABLE;INJECTION 018916-001 Jan 31, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
B Braun HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019042-004 Mar 29, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
US Army
Johnson and Johnson
Covington
Queensland Health
AstraZeneca
Healthtrust
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.